Background Neuroblastoma (NBL) is an extracranial malignant tumor in children deriving
from the neural crest in the sympathetic nervous system. Although various immunotherapy …

Aim: Neuroblastoma is the most common extracranial solid tumor in children. Recent
advances in immunotherapy Approaches, including in neuroblastoma, have shown the …

Background The prognostic value of immune-related genes and lncRNAs in neuroblastoma
has not been elucidated, especially in subgroups with different outcomes. This study aimed …

Background MYCN amplification (MNA) has been proved to be related to poor prognosis in
neuroblastoma (NBL), but the MYCN-related immune signatures and genes remain unclear …

Simple Summary People with glioblastoma (GBM) universally have poor survival despite
undergoing aggressive treatments. In this study, we aimed to determine genetic biomarkers …

Purpose Cell death plays an important role in tumourigenesis and progression;
nevertheless, the clinical significance of cell death-related genes in neuroblastoma remains …

Glioma was characterized by its severe cellular heterogeneity during cell differentiation.
Based on scRNA-seq and high throughput sequencing data, this research revealed the …

Background As one of the most important brain tumors, glioblastoma (GBM) has a poor
prognosis, especially in adults. Immune-related genes (IRGs) and immune cell infiltration …

The heterogeneity of neuroblastoma directly affects the prognosis of patients.
Individualization of patient treatment to improve prognosis is a clinical challenge at this …

Background. The clinical outcomes of low-grade glioma (LGG) are associated with T cell
infiltration, but the specific contribution of heterogeneous T cell types remains unclear …